it has the strongest evidence for GI repair including ulcers, IBD models, and gut barrier integrity Tendon-to-bone healing multiple studies show accelerated tendon repair and reattachment Neuroprotection interaction with dopaminergic and serotonergic systems Oral administration BPC-157 survives stomach acid, making it the only healing peptide with oral bioavailability Where TB-500 Has Stronger Evidence Cardiac tissue repair parent molecule (TB-4) shown to activate epicardial progenitor cells in Nature publications Muscle regeneration superior satellite cell activation and muscle fiber repair Wound healing extensive dermal wound closure data Anti-fibrotic effects reduces excessive scar tissue formation across multiple tissue types Corneal healing significant clinical research in eye injury repair Where Both Are Strong Tendon & ligament repair both show significant benefit through different pathways Anti-inflammatory effects both reduce pro-inflammatory cytokines Angiogenesis both promote new blood vessel formation (different pathways) Dosing Comparison For research and educational discussion only

For example, animal studies suggest that BPC-157 promotes neovascularization and speeds up the formation of new blood vessels that may be at risk for faster disease progression in cancer patients
Reconstituted solution at 2-8C, use within 4 weeks
Medical Science Monitor (2010)
A small subset of "sentinel" participants is dosed first, before the rest of the cohort, as an additional safeguard
Typical schedule Many people use an initial loading phase, followed by maintenance injections every 46 weeks (subject to clinician review)